Clinical Trial Update: Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings [Phase 2]

View source ↗

Summary

Phase II randomized trial comparing two nonmyeloablative conditioning regimens for allogeneic hematopoietic cell transplantation from HLA-matched donors in hema…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Snippet

Sponsor: University of Liege | Conditions: Hematological Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2022-01-26